Department of Pharmacy, National University of Singapore, 18 Science Drive 4, Singapore, 117543, Singapore.
Chem Asian J. 2018 Oct 4;13(19):2854-2867. doi: 10.1002/asia.201800729. Epub 2018 Sep 14.
Dynamic combinatorial chemistry (DCC) is a powerful supramolecular approach for discovering ligands for biomolecules. To date, most, if not all, biologically templated DCC systems employ only a single biomolecule to direct the self-assembly process. To expand the scope of DCC, herein, a novel multiprotein DCC strategy has been developed that combines the discriminatory power of a zwitterionic "thermal tag" with the sensitivity of differential scanning fluorimetry. This strategy is highly sensitive and could differentiate the binding of ligands to structurally similar subfamily members. Through this strategy, it was possible to simultaneously identify subfamily-selective probes against two clinically important epigenetic enzymes: FTO (7; IC =2.6 μm) and ALKBH3 (8; IC =3.7 μm). To date, this is the first report of a subfamily-selective ALKBH3 inhibitor. The developed strategy could, in principle, be adapted to a broad range of proteins; thus it is of broad scientific interest.
动态组合化学(DCC)是一种强大的超分子方法,可用于发现生物分子的配体。迄今为止,如果不是全部的话,大多数基于生物模板的 DCC 系统仅使用单个生物分子来指导自组装过程。为了扩展 DCC 的范围,本文开发了一种新的多蛋白 DCC 策略,该策略将两性离子“热标签”的辨别力与差示扫描荧光法的灵敏度相结合。该策略具有很高的灵敏度,可以区分配体与结构相似的亚家族成员的结合。通过该策略,可以同时鉴定针对两种临床重要的表观遗传酶的亚家族选择性探针:FTO(7;IC =2.6μm)和 ALKBH3(8;IC =3.7μm)。迄今为止,这是第一个报告的亚家族选择性 ALKBH3 抑制剂。所开发的策略原则上可以适用于广泛的蛋白质;因此,它具有广泛的科学意义。